Amrize (NYSE:AMRZ) Research Coverage Started at Oppenheimer

Oppenheimer began coverage on shares of Amrize (NYSE:AMRZ) in a report published on Tuesday morning, Marketbeat.com reports. The firm issued an outperform rating and a $62.00 target price on the stock.

Several other equities analysts have also recently weighed in on AMRZ. Zacks Research cut shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 27th. Royal Bank Of Canada dropped their target price on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 26th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.67.

Amrize Stock Up 3.3%

Shares of Amrize stock opened at $55.66 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. Amrize has a 1-year low of $44.12 and a 1-year high of $56.29.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing the consensus estimate of $1.03 by ($0.25).

Insider Transactions at Amrize

In other news, insider Stephen S. Clark purchased 5,000 shares of the business’s stock in a transaction on Friday, August 15th. The stock was purchased at an average cost of $51.82 per share, with a total value of $259,100.00. Following the acquisition, the insider directly owned 5,000 shares in the company, valued at approximately $259,100. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Ian A. Johnston purchased 10,500 shares of the business’s stock in a transaction on Friday, August 8th. The stock was purchased at an average cost of $47.71 per share, with a total value of $500,955.00. Following the completion of the acquisition, the chief financial officer owned 17,344 shares in the company, valued at approximately $827,482.24. This trade represents a 153.42% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 1,124,000 shares of company stock worth $53,225,260.

Institutional Trading of Amrize

A number of hedge funds have recently made changes to their positions in the stock. Osaic Holdings Inc. bought a new stake in shares of Amrize during the 2nd quarter worth $90,000. Orion Porfolio Solutions LLC bought a new position in shares of Amrize in the second quarter worth approximately $1,122,000. Munro Partners bought a new position in shares of Amrize in the second quarter worth approximately $1,849,000. Thrivent Financial for Lutherans bought a new position in shares of Amrize in the second quarter worth approximately $19,316,000. Finally, MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Amrize in the second quarter worth approximately $908,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.